SSA
HSTO

Schonfeld Strategic Advisors’s Histogen Inc. Common Stock HSTO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-625
Closed -$720K – 826
2017
Q2 		$720K Buy
+625
New +$761K 0.07% 332

Other funds holding HSTO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Schonfeld Strategic Advisors's HSTO Position: Q3 2017 in Review

Schonfeld Strategic Advisors sold out of Histogen Inc. Common Stock (HSTO) in Q3 2017, closing a stake of 625 shares — an estimated $720K sold.

Schonfeld Strategic Advisors first reported a position in HSTO in Q2 2017 and held it in 1 quarter. The position peaked at $720K in Q2 2017. 78 funds tracked by Wall St. Rank hold HSTO as of Q3 2017.

  • Schonfeld Strategic Advisors reported no remaining Histogen Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 625 Histogen Inc. Common Stock shares in Q3 2017, an estimated $720K.
  • Schonfeld Strategic Advisors first reported a position in Histogen Inc. Common Stock in Q2 2017 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's Histogen Inc. Common Stock position peaked at $720K in Q2 2017.
  • 78 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2017.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.